Skip to main content
logo
BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.850
-0.020 (-0.52%)
Oct 13, 2026, 9:30 AM EDT - Market open

BriaCell Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Aug - Jul.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Market Capitalization
34131410610179
Market Cap Growth
295.69%-6.05%-87.19%4.90%29.07%1427.04%
Enterprise Value
12-012775759
Last Close Price
3.877.46112.871003.50975.00762.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
PB Ratio
1.460.74-5.08-28.189.822.84
P/TBV Ratio
1.430.72--10.052.87

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Debt / Equity Ratio
-----0.00
Net Debt / Equity Ratio
-0.97-1.030.325.63-3.97-2.07
Net Debt / EBITDA Ratio
0.720.660.030.912.698.22
Net Debt / FCF Ratio
0.740.630.040.903.297.39
Quick Ratio
6.354.490.2111.8043.64102.88
Current Ratio
7.075.010.4914.9645.00103.81
Return on Equity (ROE)
-175.25%-362.56%--619.75%-141.25%-114.78%
Return on Assets (ROA)
-90.84%-123.56%-126.11%-41.71%-18.99%-14.89%
Return on Capital Employed (ROCE)
-136.40%-153.90%2097.70%-91.80%-36.70%-12.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Earnings Yield
-89.68%-205.42%-35.14%-19.08%-26.45%-17.58%
FCF Yield
-90.49%-219.93%-180.31%-22.31%-12.30%-9.86%
Buyback Yield / Dilution
-1260.31%-285.70%-5.35%-0.81%-242.82%-
SEC Filings: 10-K · 10-Q